The hedge fund’s shares of CHS are valued at $496,037. CHS makes up about 0.22 percent of Palouse Capital’s portfolio, according to Founders Daily.
Other hedge funds, including Dupont Capital Management, also reduced their stakes in CHS in the most recent quarter.
More articles on healthcare finance:
Fitch: Clinton’s healthcare plan could benefit hospitals in the near term, but long-term effects uncertain
CMS makes offer to clear Medicare appeals backlog: 6 things to know
UPMC operating margin shrinks in Q1
Next Up in Financial Management
-
Here are 10 hospitals and health systems that are seeking CFOs and assistant CFOs in recent job listings. 1. Big…
-
Boston-based Athenahealth informed employees Nov. 13 that it will eliminate 4% of its positions worldwide, The Boston Globe reported Nov.…
-
Medicaid expansion is back on the table in Georgia, Kansas, Texas and Wisconsin after Democrats won governor’s races and state…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.